Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
Hiesse
C
C
Service de Néphrologie Hôpital de Bicetre, Université Paris-Sud, France.
Gardin
J P
JP
Lantz
O
O
Cantarovich
M
M
Bensadoun
H
H
Benoit
G
G
Bellamy
J
J
Paillard
M
M
Charpentier
B
B
Fries
D
D
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D016030:Kidney Transplantation; D007684:Kidney Tubules / Q000187:drug effects / Q000502:physiology
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine